Economic Outcomes

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

Allikas‎: Anaesthesia 2019;74(12):1534-41.

Indekseeritud‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Allikas‎: Blood Adv. 2022;6(3):785-92.

Indekseeritud‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (opens new window)

HEMATOLOOGIA

Economic Outcomes

eesti

Economic Outcomes

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Haiglasidekomitee (HSK)

Meditsiiniinfo paketid

Videod

Economic Outcomes

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Haiglasidekomitee (HSK)

Meditsiiniinfo paketid

Videod

Vali keel

Jaga